A Virtual Reality Mindfulness Application for Aggression in Schizophrenia (NCT07434479)
🩺 Plain-English Summary (8th-Grade Level)
The study investigates whether a virtual reality-based mindfulness based intervention can reduce impulsive aggression in individuals with schizophrenia or schizoaffective disorder. The primary goal is to evaluate whether mindfulness delivered via VR (MBI-VR) improves emotion regulation and engages the dorsomedial prefrontal cortex (dmPFC), a brain region involved in cognitive control and regulation of emotional responses. The study also examines whether these effects show a dose-related relationship. Participants will be randomized to receive different doses of MBI-VR intervention or distraction tasks and will complete repeated mindfulness VR sessions. Brain activity will be measured using functional magnetic resonance imaging (fMRI) during an emotion regulation task, along with clinical assessments of impulsive aggression related symptoms.
Who can join: Review the eligibility criteria below.
Location: Manhattan Psychiatric Center — New York, New York
Age range: 18 Years to 64 Years
🧪 Interventions in This Study
- Mindfulness-Based Virtual Reality Intervention (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Manhattan Psychiatric Center — New York, New York
- NewYork-Presbyterian/Weill Cornell Medical Center Westchester Division — White Plains, New York
📞 Contact the Study Coordinator
Phone: (646) 766-5876
Email: anzalee.khan@nki.rfmh.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Schizophrenia Disorder
- Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder — New Orleans, Louisiana
- DecNef for AVH in Schizophrenia — New York, New York
- MicroRNAs as Biomarkers in First Episode Schizophrenia — Glen Oaks, New York
- Inter-Brain Synchrony in Schizophrenia — Los Angeles, California
Explore by condition: All Schizophrenia Disorder clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.